An Australian Patent Opposition and Extension of Term Round-Up from the Patent Office Journal dated 7 June 2012.
Opposition Proceedings
Opposition Lodged
Acceptance of the following applications has been opposed as at 7 June 2012:
| Application No. | Applicant(s) | Opponent(s) |
| 2006301929 | Biolectric Pty Ltd | Cooper Power Systems, LLC |
| 2009243419 | Geotech Airborne Limited | Fugro Airborne Surveys Corp. |
| 2010262758 | Termortar Pty Ltd | Magisurf Pty Ltd |
Opposition Withdrawn
Opposition to the acceptance of the following applications has been withdrawn as at 7 June 2012:
| Application No. | Applicant(s) | Opponent(s) |
| 2006207850 | Boliden Mineral AB | BHP Billiton SA Limited |
| 2006301914 | Bluepoint International Pty Ltd | PCAS Patient Care Automation Services Inc. |
Applications Withdrawn
The following applications have been withdrawn following opposition as at 7 June 2012:
| Application No. | Applicant(s) | Opponent(s) |
| 2007200490 | JX Nippon Mining & Metals Corporation | BHP Billiton SA Limited |
Extensions of Term of Standard Patents
Application accepted
The following application(s) for Extension of Term have been accepted under Section 74.
| Patent No. | Patentee(s) | Goods & new expiry date |
| 668144 | BTG International Ltd. | JANSSEN ABIRATERONE abiraterone acetate; 15 March 2018 |
Grant
The following application(s) for Extension of Term have been granted under Section 74.
| Patent No. | Patentee(s) | Goods & new expiry date |
| 689391 | Eli Lilly and Co. | ERAXIS anidulafungin; 19 March 2018 |
| 766618 | AstraZeneca AB | BRILINTA ticagrelor; 2 December 2024 |
| 784012 | Medarex, Inc. | YERVOY ipilimumab; 24 August 2025 |
Applications Filed
The following application(s) for Extension of Term under Section 70 have been made and are open for public inspection.
| Patent No. | Patentee(s) | Goods & First Reg. Approval |
| 2010200249 | SmithKline Beecham Biologicals (s.a.) | INFANRIX PENTA infanrix penta; 7 November 2001 |
Applications Accepted
The following application(s) for Extension of Term have been accepted under Section 74.
| Patent No. | Patentee(s) | Goods & First Reg. Approval |
| 2001263466 | Bristol-Myers Squibb Company | NULOJIX belatacept (rch); 15 March 2012 |
| 2010200249 | SmithKline Beecham Biologicals (s.a.) | INFANRIX PENTA infanrix penta; 07 November 2001 |
Extensions granted
The following application(s) for Extension of Term have been granted under Section 76.
| Patent No. | Patentee(s) | Goods & First Reg. Approval |
| 2002234640 | Boehringer Ingelheim Pharma GmbH & Co. KG | TRAJENTA Linagliptin; 01 November 2011 (pursuant to s77 expires on 01 November 2026) |
| 2006201520 | Medarex, Inc. | YERVOY ipilimumab; WINGLORE ipilimumab; 04 July 2011 (pursuant to s77 expires on 24 August 2025) |